-
1
-
-
84875641584
-
Type 2 diabetes in East Asians: Similarities and differences with populations in Europe and the United States
-
Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci 2013;1281:64-91.
-
(2013)
Ann N y Acad Sci
, vol.1281
, pp. 64-91
-
-
Ma, R.C.1
Chan, J.C.2
-
2
-
-
84943174795
-
Assessment of blood glucose regulation and safety of resistant starch formula-based diet in healthy normal and subjects with type 2 diabetes
-
Lin CH, Chang DM, Wu DJ, et al. Assessment of blood glucose regulation and safety of resistant starch formula-based diet in healthy normal and subjects with type 2 diabetes. Medicine 2015;94:e1332.
-
(2015)
Medicine
, vol.94
, pp. e1332
-
-
Lin, C.H.1
Chang, D.M.2
Wu, D.J.3
-
3
-
-
84864388040
-
Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications
-
Murea M, Ma L, Freedman BI. Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud 2012;9:6-22.
-
(2012)
Rev Diabet Stud
, vol.9
, pp. 6-22
-
-
Murea, M.1
Ma, L.2
Freedman, B.I.3
-
4
-
-
84924328397
-
Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
-
Yamagishi S, Fukami K, Matsui T. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications. Cardiovasc Diabetol 2015;14:2.
-
(2015)
Cardiovasc Diabetol
, vol.14
, pp. 2
-
-
Yamagishi, S.1
Fukami, K.2
Matsui, T.3
-
5
-
-
80053515769
-
The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus and macro vascular complications: Avenues for a mechanistic based therapeutic approach
-
Folli F, C orradi D, Fanti P, et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus and macro vascular complications: avenues for a mechanistic based therapeutic approach. Curr Diabetes Rev 2011;7:313-24.
-
(2011)
Curr Diabetes Rev
, vol.7
, pp. 313-324
-
-
Folli, F.1
Orradi, D.C.2
Fanti, P.3
-
6
-
-
84876273640
-
Hyperglycemia induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases
-
Fiorentino TV, Prioletta A, Zuo P, et al. Hyperglycemia induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharma Des 2013;19:5695-703.
-
(2013)
Curr Pharma des
, vol.19
, pp. 5695-5703
-
-
Fiorentino, T.V.1
Prioletta, A.2
Zuo, P.3
-
8
-
-
84866645242
-
Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: Role of dipeptidyl peptidase-IV inhibition
-
Rizzo MR, Barbieri M, Marfella R, et al. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012;35:2076-82.
-
(2012)
Diabetes Care
, vol.35
, pp. 2076-2082
-
-
Rizzo, M.R.1
Barbieri, M.2
Marfella, R.3
-
9
-
-
84883888603
-
Alveolar gas exchange and pulmonary functions in patients with type II diabetes mellitus
-
Anandhalakshmi S, Manikandan S, Ganeshkumar P, et al. Alveolar gas exchange and pulmonary functions in patients with type II diabetes mellitus. J Clin Diagn Res 2013;7:1874-7.
-
(2013)
J Clin Diagn Res
, vol.7
, pp. 1874-1877
-
-
Anandhalakshmi, S.1
Manikandan, S.2
Ganeshkumar, P.3
-
10
-
-
84859929091
-
Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men
-
Kwon CH, Rhee EJ, Song JK, et al. Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men. Cardiovasc Diabetol 2012;11:38.
-
(2012)
Cardiovasc Diabetol
, vol.11
, pp. 38
-
-
Kwon, C.H.1
Rhee, E.J.2
Song, J.K.3
-
11
-
-
84874931230
-
Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho dependent mechanism
-
Wang DJ, Luo P, Wang Y, et al. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho dependent mechanism. Diabetes 2013;62:1697-708.
-
(2013)
Diabetes
, vol.62
, pp. 1697-1708
-
-
Wang, D.J.1
Luo, P.2
Wang, Y.3
-
12
-
-
77949472676
-
Incretin-based therapies: New treatments for type 2 diabetes in the new millennium
-
Khoo J, Rayner CK, Jones KL, et al. Incretin-based therapies: new treatments for type 2 diabetes in the new millennium. Ther Clin Risk Manag 2009;5:683-98.
-
(2009)
Ther Clin Risk Manag
, vol.5
, pp. 683-698
-
-
Khoo, J.1
Rayner, C.K.2
Jones, K.L.3
-
13
-
-
79961222810
-
Pharmacology of dipeptidyl peptidase-4 inhibitors: Similarities and differences
-
Baetta R, Corsini A. Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences. Drugs 2011;71:1441-67.
-
(2011)
Drugs
, vol.71
, pp. 1441-1467
-
-
Baetta, R.1
Corsini, A.2
-
14
-
-
58149171060
-
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: A randomized, double-blind, placebocontrolled study
-
Defronzo RA, Fleck PR, Wilson CA, et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebocontrolled study. Diabetes Care 2008;31:2315-7.
-
(2008)
Diabetes Care
, vol.31
, pp. 2315-2317
-
-
Defronzo, R.A.1
Fleck, P.R.2
Wilson, C.A.3
-
15
-
-
84898798397
-
Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
-
Lukashevich V, Del Prato S, Araga M, et al. Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea. Diabetes Obes Metab 2014;16:403-9.
-
(2014)
Diabetes Obes Metab
, vol.16
, pp. 403-409
-
-
Lukashevich, V.1
Del Prato, S.2
Araga, M.3
-
16
-
-
79959964310
-
Guideline: Type 2 diabetes mellitus therapy: Metformin, a critical perspective
-
Pinto D, Heleno B, Gallego R, et al. Guideline: type 2 diabetes mellitus therapy: metformin, a critical perspective. Acta Med Port 2011;24:331-8.
-
(2011)
Acta Med Port
, vol.24
, pp. 331-338
-
-
Pinto, D.1
Heleno, B.2
Gallego, R.3
-
17
-
-
78651338445
-
Standards of medical care in diabetes 2007
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes 2007. Diabetes Care 2011;34(Suppl. 1):S11-61.
-
(2011)
Diabetes Care
, vol.34
, pp. S11-61
-
-
-
18
-
-
33745780301
-
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
-
Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2006;49:1711-21.
-
(2006)
Diabetologia
, vol.49
, pp. 1711-1721
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
-
19
-
-
58149335320
-
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy
-
Pratley RE, Kipnes MS, Fleck PR, et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy. Diabetes Obes Metab 2009;11:167-76.
-
(2009)
Diabetes Obes Metab
, vol.11
, pp. 167-176
-
-
Pratley, R.E.1
Kipnes, M.S.2
Fleck, P.R.3
-
20
-
-
57649225147
-
Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A multicentre, randomised, double-blind, placebo-controlled study
-
Nauck MA, Ellis GC, Fleck PR, et al. Alogliptin Study 2008 Group. Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study. Int J Clin Pract 2009;63:46-55.
-
(2009)
Int J Clin Pract
, vol.63
, pp. 46-55
-
-
Nauck, M.A.1
Ellis, G.C.2
Fleck, P.R.3
-
21
-
-
77953724336
-
Role of the glucagon-like peptide-1 receptor in the control of energy balance
-
Hayes MR, Jonghe BC, Kanoski SE. Role of the glucagon-like peptide-1 receptor in the control of energy balance. Physiol Behav 2010; 100:503-10.
-
(2010)
Physiol Behav
, vol.100
, pp. 503-510
-
-
Hayes, M.R.1
Jonghe, B.C.2
Kanoski, S.E.3
-
22
-
-
84881230708
-
Reactive aldehydes-second messengers of free radicals in diabetes mellitus
-
Jaganjac M, Tirosh O, Cohen G, et al. Reactive aldehydes-second messengers of free radicals in diabetes mellitus. Free Radic Res 2013;47:39-48.
-
(2013)
Free Radic Res
, vol.47
, pp. 39-48
-
-
Jaganjac, M.1
Tirosh, O.2
Cohen, G.3
-
23
-
-
84870242289
-
Regulation of cardiac oxidative stress and lipid peroxidation in streptozotocin-induced diabetic rats treated with aqueous extract of Pimpinella tirupatiensis tuberous root
-
Saddala RR, Thopireddy L, Ganapathi N, et al. Regulation of cardiac oxidative stress and lipid peroxidation in streptozotocin-induced diabetic rats treated with aqueous extract of Pimpinella tirupatiensis tuberous root. Exp Toxicol Pathol 2013;65:15-9.
-
(2013)
Exp Toxicol Pathol
, vol.65
, pp. 15-19
-
-
Saddala, R.R.1
Thopireddy, L.2
Ganapathi, N.3
-
24
-
-
84870571889
-
Acute blood glucose fluctuations can decrease blood glutathione and adiponectin levels in patients with type 2 diabetes
-
Tsai CJ, Hsieh CJ, Tung SC, et al. Acute blood glucose fluctuations can decrease blood glutathione and adiponectin levels in patients with type 2 diabetes. Diabetes Res Clin Prac 2012;98:257-63.
-
(2012)
Diabetes Res Clin Prac
, vol.98
, pp. 257-263
-
-
Tsai, C.J.1
Hsieh, C.J.2
Tung, S.C.3
-
25
-
-
84884915819
-
Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC
-
Patel H, Chen J, Das KC, et al. Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC. Cardiovasc Dialectol 2013;12:142-6.
-
(2013)
Cardiovasc Dialectol
, vol.12
, pp. 142-146
-
-
Patel, H.1
Chen, J.2
Das, K.C.3
-
27
-
-
34250710080
-
Lung function changes related to diabetes mellitus
-
Hsia CC, Raskin P. Lung function changes related to diabetes mellitus. Diabetes Technol Ther 2007;9(Suppl 1):S73-82.
-
(2007)
Diabetes Technol Ther
, vol.9
, pp. S73-82
-
-
Hsia, C.C.1
Raskin, P.2
-
28
-
-
0033366583
-
Body mass index, diabetes, and C-reactive protein among U S adults
-
Ford E. Body mass index, diabetes, and C-reactive protein among U. S. adults. Diabetes Care 1999;22:1971-7.
-
(1999)
Diabetes Care
, vol.22
, pp. 1971-1977
-
-
Ford, E.1
-
29
-
-
0345102427
-
Increased levels of C-reactive protein in noncontrolled type 2 diabetic subjects
-
Rodriguez M, Guerrero R. Increased levels of C-reactive protein in noncontrolled type 2 diabetic subjects. J Diabetes Complications 1999; 13:211-5.
-
(1999)
J Diabetes Complications
, vol.13
, pp. 211-215
-
-
Rodriguez, M.1
Guerrero, R.2
-
30
-
-
0036172495
-
Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus
-
Tan K, ChowW, Tam S, et al. Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab 2002;87:563-8.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 563-568
-
-
Tan, K.1
Chow, W.2
Tam, S.3
-
31
-
-
0013088326
-
The role of inflammation and anti-inflammatorymedication in asthma
-
Barnes PJ. The role of inflammation and anti-inflammatorymedication in asthma. Respir Med 2002;96(Suppl A):S9-15.
-
(2002)
Respir Med
, vol.96
, pp. S9-15
-
-
Barnes, P.J.1
-
32
-
-
0023089068
-
Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus
-
Sandler M, Bunn A, Stewart R. Cross-section study of pulmonary function in patients with insulin-dependent diabetes mellitus. Am Rev Respir Dis 1987;135:223-8.
-
(1987)
Am Rev Respir Dis
, vol.135
, pp. 223-228
-
-
Sandler, M.1
Bunn, A.2
Stewart, R.3
-
33
-
-
0031446351
-
Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus
-
Niranjan V, McBrayer DG, Ramirez LC, et al. Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J 1997;103:504-13.
-
(1997)
Am J
, vol.103
, pp. 504-513
-
-
Niranjan, V.1
McBrayer, D.G.2
Ramirez, L.C.3
-
34
-
-
0034308197
-
Reduced pulmonary function and its associations in type 2 diabetes: The Fremantle Diabetes Study
-
Davis TM, Knuiman M, Kendall P, et al. Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 2000;50:153-9.
-
(2000)
Diabetes Res Clin Pract
, vol.50
, pp. 153-159
-
-
Davis, T.M.1
Knuiman, M.2
Kendall, P.3
-
35
-
-
0029905056
-
NIDDM, impaired glucose tolerance, and pulmonary function in older adults
-
The Rancho Bernardo Study
-
Barrett-Connor E, Frette C. NIDDM, impaired glucose tolerance, and pulmonary function in older adults. The Rancho Bernardo Study. Diabetes Care 1996;1441-4.
-
(1996)
Diabetes Care
, pp. 1441-1444
-
-
Barrett-Connor, E.1
Frette, C.2
-
36
-
-
0024533304
-
Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study
-
Lange P, Groth S, Kastrup J, et al. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J 1989;2:14-9.
-
(1989)
Eur Respir J
, vol.2
, pp. 14-19
-
-
Lange, P.1
Groth, S.2
Kastrup, J.3
-
37
-
-
34547863123
-
Sitagliptin Study 035 Group Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
-
Hermansen K, Kipnes M, Luo E, et al. Sitagliptin Study 035 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Diabetes Obes Metab 2007;9:733-45.
-
(2007)
Diabetes Obes Metab
, vol.9
, pp. 733-745
-
-
Hermansen, K.1
Kipnes, M.2
Luo, E.3
-
38
-
-
0025220777
-
Diabetes mellitus and ventilatory capacity: A five year follow-up study
-
Lange P, Groth S, Mortensen J, et al. Diabetes mellitus and ventilatory capacity: a five year follow-up study. Eur Respir J 1990;3:288-92.
-
(1990)
Eur Respir J
, vol.3
, pp. 288-292
-
-
Lange, P.1
Groth, S.2
Mortensen, J.3
-
39
-
-
0036900816
-
Copenhagen City Heart Study: Longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults
-
Lange P, Parner J, Schnohr P, et al. Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J 2002;20:1406-12.
-
(2002)
Eur Respir J
, vol.20
, pp. 1406-1412
-
-
Lange, P.1
Parner, J.2
Schnohr, P.3
-
40
-
-
0035097211
-
Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese non-diabetic subjects
-
Mannucci E, Ognibene A, Cremasco F, et al. Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese non-diabetic subjects. Diabetes Care 2001;24:489-94.
-
(2001)
Diabetes Care
, vol.24
, pp. 489-494
-
-
Mannucci, E.1
Ognibene, A.2
Cremasco, F.3
-
41
-
-
84969878808
-
Association of traditional Chinese medicine therapy and the risk of vascular complications in patients with type II diabetes mellitus: A nationwide, retrospective, Taiwanese-registry, cohort study
-
Lee AL, Chen BC, Mou CH, et al. Association of traditional Chinese medicine therapy and the risk of vascular complications in patients with type II diabetes mellitus: a nationwide, retrospective, Taiwanese-registry, cohort study. Medicine 2016;95:2356-62.
-
(2016)
Medicine
, vol.95
, pp. 2356-2362
-
-
Lee, A.L.1
Chen, B.C.2
Mou, C.H.3
|